Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenetic Biosciences (XBIO) Other Accumulated Expenses (2024 - 2025)

Xenetic Biosciences (XBIO) has disclosed Other Accumulated Expenses for 2 consecutive years, with $70000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Accumulated Expenses changed N/A year-over-year to $70000.0, compared with a TTM value of $70000.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $100000.0, changed N/A over the prior year.
  • Other Accumulated Expenses was $70000.0 for Q3 2025 at Xenetic Biosciences, down from $200000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $200000.0 in Q2 2025 and bottomed at $70000.0 in Q3 2025.